Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Tumour”

8,700 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 8,700 results

Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02089685
What this trial is testing

Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)

Who this might be right for
Renal Cell CarcinomaMelanoma
Merck Sharp & Dohme LLC 295
Not applicableNot Yet RecruitingNCT07538791
What this trial is testing

Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)

Who this might be right for
Pheochromocytomas and ParagangliomasPheochromocytomasParagangliomas
Azienda USL Reggio Emilia - IRCCS 210
Testing effectiveness (Phase 2)Study completedNCT00007982
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

Who this might be right for
Brain and Central Nervous System TumorsHead and Neck CancerLymphoma
Herbert Irving Comprehensive Cancer Center 30
Early research (Phase 1)Active Not RecruitingNCT05768880
What this trial is testing

Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

Who this might be right for
Diffuse Intrinsic Pontine GliomaDiffuse Midline GliomaRecurrent CNS Tumor, Adult+2 more
Seattle Children's Hospital 72
Testing effectiveness (Phase 2)Study completedNCT05419388
What this trial is testing

Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
Hoffmann-La Roche 93
Early research (Phase 1)Ended earlyNCT00516282
What this trial is testing

VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 14
Not applicableStudy completedNCT04146324
What this trial is testing

An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia

Who this might be right for
Melanoma
Bristol-Myers Squibb 150
Not applicableStudy completedNCT07429123
What this trial is testing

Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers

Who this might be right for
Skin ConditionSkin AbnormalitiesMalignancy+2 more
AI Labs Group S.L 131
Early research (Phase 1)WithdrawnNCT02068079
What this trial is testing

A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma

Who this might be right for
Melanoma
Duke University
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Not applicableStudy completedNCT04253574
What this trial is testing

Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma

Who this might be right for
Malignant Melanoma
University of Basel 258
Testing effectiveness (Phase 2)Looking for participantsNCT07038096
What this trial is testing

ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

Who this might be right for
Small Cell Lung CancerNeuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 350
Testing effectiveness (Phase 2)Ended earlyNCT00707161
What this trial is testing

Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma

Who this might be right for
CancerMelanoma
University of Utah 6
Testing effectiveness (Phase 2)Ended earlyNCT00003476
What this trial is testing

Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

Who this might be right for
Childhood Brain Tumor
Burzynski Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT00398320
What this trial is testing

Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Pamela L. Kunz 40
Testing effectiveness (Phase 2)Ended earlyNCT01026324
What this trial is testing

Dinaciclib in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Stage IIIB MelanomaStage IIIC MelanomaStage IV Melanoma
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00590343
What this trial is testing

Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors

Who this might be right for
Metastatic Neuroendocrine Tumors
Louisiana State University Health Sciences Center in New Orleans 23
Load More Results